A two-gene signature, SKI and SLAMF1, predicts time-to-treatment in previously untreated patients with chronic lymphocytic leukemia

Carmen D. Schweighofer, Kevin R. Coombes, Lynn L. Barron, Lixia Diao, Rachel J. Newman, Alessandra Ferrajoli, Susan O'Brien, William G. Wierda, Rajyalakshmi Luthra, L. Jeffrey Medeiros, Michael J. Keating, Lynne V. Abruzzo

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'A two-gene signature, SKI and SLAMF1, predicts time-to-treatment in previously untreated patients with chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences

Agriculture & Biology

Chemical Compounds